Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: insights qualified medical interpreters key in improving health equity
… Key Themes and Insights From ASCO 2024: A Glimpse Into the … purposes, such as understanding how their product performs in real-world settings, identifying gaps in care, conducting … as well as expertise in integrated evidence planning, medical communications, and global health technology …
… Solutions This is part two of a three-part series on improving health equity in research. Read the other two articles here. Part 1: What … pharmaceutical developers to submit plans for diversifying medical research participation to help meet the needs of …
… world data—from administrative claims data, electronic medical records (EMRs), disease registries, and other health … success. Using database studies, we can help you can gain insights on: Burden (cost) of illness Cost of treatment … research questions. Research Methods Our advantage lies in our research team and the scientific rigor they bring to …
… Resource Group This is part one of a three-part series on improving health equity in research. Read the other two articles here: Part 2: … oppression intersect and shape people’s health outcomes is key to identifying and addressing health disparities. …
… Webinar: Addressing Challenges in Health Equity Research Share on: Wednesday, November 8, … involved in the development of pharmaceuticals, medical devices, diagnostics, digital therapies, or public …
… Global Forum for Qualified Persons for Pharmacovigilance (QPPV) Share on: … an epidemiologist perspective on true adverse reactions in pharma research at the DIA, Global Forum for Qualified Persons for Pharmacovigilance. True adverse …
… Medical Communications and Strategy As HEOR and RWE continue to grow in importance, it is critical to communicate them clearly and … in HEOR and RWE data and how to communicate it. Our Medical Communications and Strategy Team Offers: Extensive …
… a current member of NICE’s appraisal committee, the Chief Medical Officer of a major private US insurer, and the … and therapeutics committees—to gain the most useful insights about your product, its competitors, and the current … typically with the following sections: Executive summary: Key product value messages and links to key background …
… we’ve acquired from working on hundreds of different drugs in nearly every therapeutic area to help commercialize your … demonstrate the economic value of your pharmaceutical and medical products. Expertise for Every Product Lifecycle Stage … and research plans at the right time to create real-world insights about your product. Our pharmacoeconomics experts, …
… Information Exchange (PIE) Materials Unapproved Medical Product Dossiers and Unapproved Use Dossiers An … or an unapproved use dossier, allows you to communicate key product information—including clinical evidence—to US payors well in advance of approval. Let our team of experts help you …